Dr Kate Lifford

2026

• Kempers, E. et al., 2026. Discontinuation of anticoagulants and occurrence of bleeding and thromboembolic events in vitamin K antagonist users with a life-limiting disease. Thrombosis and Haemostasis 126 (7), pp.714-728. (10.1055/a-2524-5334)
• Purchase, T. et al. 2026. Fighting to be heard: Thematic analysis of parent perspectives of safety in general practice. British Journal of General Practice (10.3399/BJGP.2025.0651)
• Purchase, T. et al. 2026. Co-generating ideas for safer paediatric care in general practice with parents and stakeholders. British Journal of General Practice (10.3399/BJGP.2025.0690)
• Baddeley, E. et al. 2026. Clinician perspectives on antithrombotic therapy management in advanced cancer: a multi-national qualitative study. Research and Practice in Thrombosis and Haemostasis 10 (3) 103427. (10.1016/j.rpth.2026.103427)
• Mahé, I. et al., 2026. Developing a decision support tool for the continuation or deprescribing of antithrombotic therapy in patients receiving end-of-life care: Results of a European Delphi study. Thrombosis Research: Vascular Obstruction, Hemorrhage and Hemostasis 258 109573. (10.1016/j.thromres.2025.109573)

2025

• Aldridge, S. J. et al., 2025. Anti‐thrombotic therapy in patients with cancer at the end of life and associated clinical outcomes: A cohort study using population‐linked routinely collected data. British Journal of Haematology 207 (5), pp.2080-2090. (10.1111/bjh.70032)
• Baddeley, E. et al. 2025. "Who am I to say that I'm not going to take it": patient perspectives on decisions about antithrombotic therapy in the context of advanced cancer. Thrombosis Research: Vascular Obstruction, Hemorrhage and Hemostasis 253 109399. (10.1016/j.thromres.2025.109399)
• Deneche, I. et al., 2025. Developing a decision support tool for the continuation or deprescribing of antithrombotic therapy in patients receiving end-of-life care: Protocol for a European Delphi study. Thrombosis Update 19 100209. (10.1016/j.tru.2025.100209)
• Kempers, E. K. et al., 2025. Determining drug exposure based on medication dispensing data: a validation study of vitamin K antagonist treatment episodes against INR records. Pharmacoepidemiology & Drug Safety 34 (6) e70158. (10.1002/pds.70158)
• Morgan, J. L. et al., 2025. Preferences for quality of life versus length of life in older women deciding about treatment for early breast cancer: A cross-sectional sub-analysis of the Bridging the Age Gap study. Journal of Geriatric Oncology 16 (4) 102226. (10.1016/j.jgo.2025.102226)
• Visser, C. et al., 2025. Quality of vitamin K antagonist treatment during the last year of life. HemaSphere 9 (5) e70135. (10.1002/hem3.70135)
• Williams, D. et al. 2025. Recommendations for a communication strategy to support informed decision-making about self or clinician sampling for cervical screening in the UK: qualitative study. Health Expectations 28 (2) e70191. (10.1111/hex.70191)
• Mackay, O. et al. 2025. Identifying optimum implementation for human papillomavirus self-sampling in underserved communities: A systematic review. Journal of Medical Screening 32 (1), pp.2-18. (10.1177/09691413241274312)

2024

• Ali, O. et al. 2024. Acceptability of alternative technologies compared with faecal immunochemical test and/or colonoscopy in colorectal cancer screening: A systematic review. Journal of Medical Screening 30 (1), pp.14-27. (10.1177/09691413221109999)
• Lifford, K. J. et al. 2024. Satisfaction with remote consultations in primary care during COVID-19: a population survey of UK adults. British Journal of General Practice 74 (739), pp.e96-e103. (10.3399/BJGP.2023.0092)

2023

• Mann, M. et al. 2023. What are the most effective interventions to support children and young people bereaved by suicide in the family: a rapid review. [Online].MedRXiv. (10.1101/2023.09.13.23295481)Available at: https://doi.org/10.1101/2023.09.13.23295481.
• Goedegebuur, J. et al., 2023. Towards optimal use of antithrombotic therapy of people with cancer at the end of life: a research protocol for the development and implementation of the SERENITY shared decision support tool. Thrombosis Research 228 , pp.54-60. (10.1016/j.thromres.2023.05.008)

2022

• Semedo, L. et al. 2022. Participants' experiences of the management of screen-detected complex polyps within a structured bowel cancer screening programme. Health Expectations 25 (5), pp.2355-2364. (10.1111/hex.13525)
• Wyld, L. et al., 2022. Improving outcomes for women aged 70 years or above with early breast cancer: research programme including a cluster RCT. Programme Grants for Applied Research 10 6. (10.3310/XZOE2552)
• Dorgeat, E. et al. 2022. Effectiveness of technological interventions to improve healthcare communication with children with long-term conditions: a systematic review and meta-analysis of randomised controlled trials. Patient Education and Counseling 105 (6), pp.1411-1426. (10.1016/j.pec.2021.09.033)

2021

• Field, J. K. et al., 2021. Results from the randomised UKLS trial: Lung cancer mortality reduction by LDCT screening confirmed in an international meta-analysis. The Lancet 10 100179. (10.1016/j.lanepe.2021.100179)
• Battisti, N. M. L. et al., 2021. Observational cohort study in older women with early breast cancer: Use of radiation therapy and impact on health-related quality of life and mortality. Radiotherapy and Oncology 161 , pp.166-176. (10.1016/j.radonc.2021.06.021)
• Ring, A. et al., 2021. Bridging The Age Gap: observational cohort study of effects of chemotherapy and trastuzumab on recurrence, survival and quality of life in older women with early breast cancer. British Journal of Cancer 125 , pp.209-219. (10.1038/s41416-021-01388-9)
• Burton, M. et al., 2021. Process evaluation of the Bridging the Age Gap in Breast Cancer decision support intervention cluster randomised trial. Trials 22 447. (10.1186/s13063-021-05360-z)
• Holmes, G. R. et al., 2021. Cost-effectiveness modeling of surgery plus adjuvant endocrine therapy versus primary endocrine therapy alone in UK women aged 70 and over with early breast cancer. Value in Health 24 (6), pp.770-779. (10.1016/j.jval.2020.12.016)
• Martin, C. et al., 2021. Treatment choices for older women with primary operable breast cancer and cognitive impairment: Results from a prospective, multicentre cohort study. Journal of Geriatric Oncology 12 (5), pp.705-713. (10.1016/j.jgo.2020.12.006)
• Wyld, L. et al., 2021. Bridging the age gap in breast cancer: cluster randomised trial of the effects of two decision support interventions for older women with operable breast cancer on quality-of-life, survival, decision quality and treatment choices. British Journal of Surgery 108 (5), pp.499-510. (10.1093/bjs/znab005)
• Semedo, L. et al. 2021. Development and user-testing of a brief decision aid for aspirin as a preventive approach alongside colorectal cancer screening.. BMC Medical Informatics and Decision Making 21 165. (10.1186/s12911-021-01523-9)
• Morgan, J. L. et al., 2021. Bridging the age gap in breast cancer: impact of omission of breast cancer surgery in older women with oestrogen receptor-positive early breast cancer on quality-of-life outcomes. British Journal of Surgery 108 (3), pp.315–325. (10.1093/bjs/znaa125)
• Battist, N. M. L. et al., 2021. Bridging the age gap in breast cancer: Impact of chemotherapy on quality of life in older women with early breast cancer. European Journal Of Cancer 144 , pp.269-280. (10.1016/j.ejca.2020.11.022)
• Morgan, J. L. et al., 2021. Observational cohort study to determine the degree and causes of variation in the rate of surgery or primary endocrine therapy in older women with operable breast cancer. EJSO - European Journal of Surgical Oncology 47 (2), pp.261-268. (10.1016/j.ejso.2020.09.029)
• Wyld, L. et al., 2021. Bridging the age gap in breast cancer. Impacts of omission of breast cancer surgery in older women with oestrogen receptor positive early breast cancer. A risk stratified analysis of survival outcomes and quality of life. European Journal of Cancer 142 , pp.48-62. (10.1016/j.ejca.2020.10.015)

2019

• Phillips, G. et al. 2019. Do published patient decision aids for end-of-life care address patients' decision making needs? A systematic review and critical appraisal. Palliative Medicine 33 (8), pp.985-1002. (10.1177/0269216319854186)
• Lifford, K. J. et al. 2019. Efficient development and usability testing of decision support interventions for older women with breast cancer.. Patient Preference and Adherence 2019 (13), pp.131-143. (10.2147/PPA.S178347)

2017

• Burton, M. et al., 2017. Information needs and decision making preferences of older women offered a choice between surgery and primary endocrine therapy for early breast cancer. Psycho-Oncology 26 (12), pp.2094-2100. (10.1002/pon.4429)
• Brain, K. et al. 2017. Impact of low-dose CT screening on smoking cessation among high-risk participants in the UK Lung Cancer Screening Trial. Thorax 72 (10), pp.912-918. (10.1136/thoraxjnl-2016-209690)
• Dunn, C. E. et al., 2017. The role of screening expectations in modifying short-term psychological responses to low-dose computed tomography lung cancer screening among high-risk individuals. Patient Education and Counseling 100 (8), pp.1572-1579. (10.1016/j.pec.2017.02.024)
• Collins, K. et al., 2017. Bridging the age gap in breast cancer: evaluation of decision support interventions for older women with operable breast cancer: protocol for a cluster randomised controlled trial. BMJ Open 7 (7) e015133. (10.1136/bmjopen-2016-015133)

2016

• Brain, K. et al. 2016. Long-term psychosocial outcomes of low dose computed tomography screening: results of the UK Lung Cancer Screening (UKLS) randomised controlled trial. Thorax 71 (11), pp.996-1005. (10.1136/thoraxjnl-2016-208283)
• Field, J. K. et al., 2016. The UK Lung Cancer Screening Trial: a pilot randomised controlled trial of low-dose computed tomography screening for the early detection of lung cancer. Health Technology Assessment 20 (40)(10.3310/hta20400)
• Field, J. K. et al., 2016. UK Lung Cancer RCT Pilot Screening Trial: baseline findings from the screening arm provide evidence for the potential implementation of lung cancer screening. Thorax 71 (2), pp.161-170. (10.1136/thoraxjnl-2015-207140)

2015

• Morgan, J. L. et al., 2015. The balance of clinician and patient input into treatment decision-making in older women with operable breast cancer. Psycho-Oncology 24 (12), pp.1761-1766. (10.1002/pon.3853)
• Burton, M. et al., 2015. The information and decision support needs of older women (>75 yrs) facing treatment choices for breast cancer: a qualitative study. Psycho-Oncology 24 (8), pp.878-884. (10.1002/pon.3735)
• Ali, N. et al. 2015. Barriers to uptake among high-risk individuals declining participation in lung cancer screening: a mixed methods analysis of the UK Lung Cancer Screening (UKLS) trial. BMJ Open 5 (7) e008254. (10.1136/bmjopen-2015-008254)
• Lifford, K. et al. 2015. Understanding older women's decision making and coping in the context of breast cancer treatment. BMC Medical Informatics and Decision Making 15 (1)(10.1186/s12911-015-0167-1)

2014

• McRonald, F. E. et al., 2014. The UK Lung Screen (UKLS): demographic profile of first 88,897 approaches provides recommendations for population screening. Cancer Prevention Research 7 (3), pp.362-371. (10.1158/1940-6207.CAPR-13-0206)

2013

• Lifford, K. et al. 2013. Catalysts to withdrawal from familial ovarian cancer screening for surgery and reactions to discontinued screening: a qualitative study. Familial Cancer 12 (1), pp.19-26. (10.1007/s10689-012-9567-x)
• Lifford, K. J. et al. 2013. A qualitative study of women's experiences of familial ovarian cancer screening. Psycho-Oncology 22 (11), pp.2576-2584. (10.1002/pon.3324)

2012

• Brain, K. E. et al. 2012. Psychological outcomes of familial ovarian cancer screening: No evidence of long-term harm. Gynecologic Oncology 127 (3), pp.556-563. (10.1016/j.ygyno.2012.08.034)
• Lifford, K. J. et al. 2012. Withdrawal from familial ovarian cancer screening for surgery: Findings from a psychological evaluation study (PsyFOCS). Gynecologic Oncology 124 (1), pp.158-163. (10.1016/j.ygyno.2011.09.015)

2009

• Lifford, K. J. , Harold, G. T. and Thapar, A. 2009. Parent–child hostility and child ADHD symptoms: a genetically sensitive and longitudinal analysis. Journal of Child Psychology and Psychiatry 50 (12), pp.1468-1476. (10.1111/j.1469-7610.2009.02107.x)

2008

• Lifford, K. J. , Harold, G. T. and Thapar, A. 2008. Parent-child relationships and ADHD symptoms: a longitudinal analysis. Journal of Abnormal Child Psychology 36 (2), pp.285-296. (10.1007/s10802-007-9177-5)

2007

• Rice, F. et al. 2007. Mental health and functional outcomes of maternal and adolescent reports of adolescent depressive symptoms. Journal of the American Academy of Child & Adolescent Psychiatry 46 (9), pp.1162-1170. (10.1097/chi.0b013e3180cc255f)
• Fowler, T. A. et al. 2007. Exploring the relationship between genetic and environmental influences on initiation and progression of substance use. Addiction 102 (3), pp.413-422. (10.1111/j.1360-0443.2006.01694.x)
• Shelton, K. H. et al. 2007. The association between conduct problems and the initiation and progression of marijuana use during adolescence: A genetic analysis across time. Behavior Genetics 37 (2), pp.314-325. (10.1007/s10519-006-9124-1)
• van den Bree, M. B. et al. 2007. The Cardiff Study of All Wales and North West of England Twins (CaStANET): A longitudinal research program of child and adolescent development. Twin Research and Human Genetics 10 (01), pp.13-23. (10.1375/twin.10.1.13)
• Fowler, T. et al. 2007. Genetic and environmental influences on the relationship between peer alcohol use and own alcohol use in adolescents. Addiction 102 (6), pp.894-903. (10.1111/j.1360-0443.2007.01824.x)